Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs NTR✓SelectedUSD · NTRGSK vs NTR performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs NTR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+94.9%
NTR return
+66.3%
Excess return
+28.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioNTRExcessAlpha
1D-1.6%-0.8%-0.8%-1.5%
7D-4.7%-8.2%+3.4%-3.7%
30D-4.7%-5.2%+0.5%-4.0%
3M-8.8%-6.5%-2.2%-8.1%
6M-4.6%-7.1%+2.5%-3.9%
YTD+1.0%+8.5%-7.6%-1.1%
1Y+6.9%+19.8%-12.9%+3.1%
3Y+52.5%+27.6%+25.0%+43.9%
5Y+40.3%+12.1%+28.2%+29.4%
All+94.9%+66.3%+28.6%+59.5%

Cumulative growth

Daily Returns

Daily percentage return beside NTR.

Daily Out/Under-Performance

Portfolio return minus NTR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NTR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded NTR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling